Armata Pharmaceuticals, Inc.·4

Mar 26, 7:33 PM ET

Martin Steven Robert 4

4 · Armata Pharmaceuticals, Inc. · Filed Mar 26, 2021

Insider Transaction Report

Form 4
Period: 2021-03-25
Martin Steven Robert
Chief Financial Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2021-03-25+56,00056,000 total
    Exercise: $5.14Exp: 2031-03-25Common Stock (56,000 underlying)
Footnotes (1)
  • [F1]The stock option vests as to twenty-five percent (25%) of the underlying shares of common stock on each of the first, second, third and fourth annual anniversaries of the date of grant.

Documents

1 file
  • 4
    tm2111079-1_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT